Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × Resveratrol × Clear all

Phase

Status

Completed 6 Withdrawn 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cisplatin 442 Cyclophosphamide 309 Radiotherapy 307 Carboplatin 295 Paclitaxel 281 Capecitabine 276 Oxaliplatin 268 Docetaxel 268 Gemcitabine 264 Fluorouracil 239 apatinib 217 Drug Therapy 194 Bevacizumab 185 camrelizumab 178 Etoposide 172 Irinotecan 152 Doxorubicin 150 Leucovorin 131 Dexamethasone 130 Cytarabine 125 sintilimab 115 Pemetrexed 113 anlotinib 110 pembrolizumab 108 toripalimab 105 Rituximab 104 S 1 (combination) 103 Vincristine 101 Neoadjuvant Therapy 101 fludarabine 95

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡